Philip Gutry appointed as Chief Business Officer by Kronos Bio

Vaccines |  News | 0 Comment | 28 Nov, 2018

U.S. based Kronos Bio has announced that it has appointed Philip Gutry as its Chief Business Officer. In this newly created role, Philip will drive the company’s business development...Read more

Esco, Nuvonis enter into MoU to support novel vaccines in Asia

Vaccines |  News | 0 Comment | 04 Oct, 2018

Singapore - Esco Aster (Singapore) and Nuvonis Technologies (Austria) will sign a Memorandum of Understanding (MoU) for the early development and manufacturing of viral vaccines prevalent i...Read more

Enesi, Public Health England carry out R&D collaboration

Vaccines |  News | 0 Comment | 03 Oct, 2018

Singapore - Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dosevaccine products, announces it has entered a researc...Read more

GSK TB vaccine shows promise in phII study

Vaccines |  News | 0 Comment | 30 Sep, 2018

Pharma giant GSK and Aeras reported that GSK’s candidate vaccine significantly reduced the incidence of pulmonary tuberculosis disease in HIV-negative adults with latent tuberculosis ...Read more

Rotavirus vaccine options expand with WHO’s prequalification

Vaccines |  News | 0 Comment | 28 Sep, 2018

PATH welcomes the World Health Organization's (WHO's) prequalification of the thermostable rotavirus vaccine, ROTASIIL, manufactured by Serum Institute of India. The vaccine, which pre...Read more

Inovio Pharma, Geneone Lifesciences announce Ph1 study of Hep C vaccine

Vaccines |  News | 0 Comment | 13 Sep, 2018

Inovio Pharmaceuticals and Korea's GeneOne Life Science have announced that they have dosed the first patient in a Phase 1 study designed to evaluate a preventive vaccine against hepatitis ...Read more

India loses its vaccine export sheen

Vaccines |  News | 0 Comment | 14 Aug, 2018

India, once called as the vaccine capital, is slowly losing its sheen because of various reasons, primarily the aggressive marketing strategy of China and Korea and the lacklustre policies ...Read more

Changchun Changsheng Life Sciences to stop output after drug safety scandal

Vaccines |  News | 0 Comment | 23 Jul, 2018

China Food and Drug Administration (CFDA) has issued an announcement asking Changchun Changsheng Life Sciences, China’s second-biggest rabies vaccine maker, to terminate the productio...Read more

Esco, Konkuk University cooperate on pigs vaccine in Asia

Vaccines |  News | 0 Comment | 02 Jul, 2018

Singapore – Esco Aster, a leading independent contract development and manufacturing organization with its patent Tide Motion bioreactor technology, has signed a collaborative researc...Read more

FDA grants priority review to Merck's sBLA for HPV vaccine

Vaccines |  News | 0 Comment | 13 Jun, 2018

Merck, known as MSD outside the United States and Canada, has announced that the US Food and Drug Administration (FDA) has accepted for review a new supplemental Biologics License Applicati...Read more

UNAIDS calls for an increase in vaccine research

Vaccines |  News | 0 Comment | 18 May, 2018

On HIV Vaccine Awareness Day, 18 May, UNAIDS is calling for an increase in research and investment to find an effective vaccine to protect people against HIV and stop new HIV infections. In...Read more

Experts team up during Pneumonia Awareness Week

Vaccines |  News | 0 Comment | 14 May, 2018

Researchers, doctors and patients have teamed with Lung Foundation Australia during this week’s Pneumonia Awareness Week to call for proactive community action to address the dec...Read more

WHO starts its first Cholera vaccine campaign in Yemen

Vaccines |  News | 0 Comment | 08 May, 2018

The first vaccine campaign against cholera in Yemen has been started by the World Health Organization (WHO), a year and a half after an epidemic was triggered by war and a health and sanita...Read more

Sinovac Announces Preliminary Results of Phase III Trial on sIPV

Vaccines |  News | 0 Comment | 19 Apr, 2018

Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced preliminary results of a phase III clinical study on Sabin inactivated polio vaccine (“sIPV&r...Read more

Oxford Vacmedix raises $12.5 M from Chinese & Korean investors

Vaccines |  News | 0 Comment | 08 Mar, 2018

Oxford Vacmedix UK Limited (OVM), a UK-based biopharma company and a spin out of Oxford University Innovation, is commercializing the research developed as a partnership between Oxford Univ...Read more

McGill scientists develop a TB vaccine that induces innate response via Bone Marrow Stem Cells

Vaccines |  News | 0 Comment | 17 Jan, 2018

Attempts to stimulate the adaptive immune system against TB have yielded uneven results. The existing BCG vaccine is only partially effective, and vaccines in development give disappointmen...Read more

CCMD offers inexpensive treatment for Hepatitis C

Vaccines |  News | 0 Comment | 01 Jan, 2018

CCM Duopharma Biotech Berhad (CCMD) is a subsidiary of Chemical Company of Malaysia Berhad that has seven pharmaceutical units under its umbrella. Company is engaged in the development, ma...Read more

NIH study finds clues about why common cancer drug causes hearing loss

Vaccines |  News | 0 Comment | 21 Dec, 2017

Scientists at NIH have found a new way to explain the hearing loss caused by cisplatin, a powerful drug used to treat many forms of cancer. Using a highly sensitive technique to measure an...Read more